Can radiomics and AI characterize renal masses on preop CT?
The combination of radiomics and a machine-learning algorithm can differentiat...Read more on AuntMinnie.comRelated Reading: Deep-learning algorithm spots kidney stones on CT exams CT shows that acute kidney injury common among COVID-19 patients Ultrasound AI model can help evaluate chronic kidney disease AI plus CT improves liver steatosis assessment AI could help radiologists better detect kidney cancer (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - September 17, 2021 Category: Radiology Source Type: news

Kidney cancer: Persistent back troubles? The lesser-known warning sign of the disease
KIDNEY cancer incidence rates are expected to rise by 26 percent in the UK between 2014 and 2035, to 32 cases per 100,000 people by 2035, according to Cancer Research UK. Spotting the early signs of the disease is crucial, as with most conditions, particularly if ongoing back pain is part of your life. (Source: Daily Express - Health)
Source: Daily Express - Health - September 10, 2021 Category: Consumer Health News Source Type: news

Breakthrough on heart attack care: Kidney cancer drug 'heals heart and prevents second attack'
An injection of kidney and skin cancer medicine aldesleukin increases levels of a rare white blood cell that protects the heart, researchers at Cambridge University found. (Source: the Mail online | Health)
Source: the Mail online | Health - September 6, 2021 Category: Consumer Health News Source Type: news

Adjuvant Pembrolizumab Beneficial in Renal Cell Carcinoma
Rate of disease - free survival at 24 months higher with pembrolizumab versus placebo following nephrectomy (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - August 19, 2021 Category: Cancer & Oncology Tags: Nephrology, Oncology, Pharmacy, Journal, Source Type: news

Adjuvant Pembrolizumab Beneficial in Renal Cell Carcinoma
THURSDAY, Aug. 19, 2021 -- For patients with clear-cell renal cell carcinoma at high risk for recurrence after nephrectomy, adjuvant therapy with pembrolizumab improves disease-free survival, according to a study published in the Aug. 19 issue of... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - August 19, 2021 Category: Pharmaceuticals Source Type: news

' Dawn of a New Era' in the Treatment of Renal Cell Carcinoma'Dawn of a New Era' in the Treatment of Renal Cell Carcinoma
Adjuvant pembrolizumab demonstrates significant disease-free survival benefit without excess toxicity in patients at high risk of recurrence.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - August 18, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

FDA OKs Belzutifan for Cancers Tied to von Hippel-Lindau Disease FDA OKs Belzutifan for Cancers Tied to von Hippel-Lindau Disease
The new drug is for patients with von Hippel-Lindau disease who require therapy for a number of associated cancers, including renal cell carcinoma.FDA Approvals (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - August 13, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Alert Source Type: news

FDA OKs Pembro Plus Lenvatinib For First-Line in Kidney Cancer FDA OKs Pembro Plus Lenvatinib For First-Line in Kidney Cancer
Results from the phase 3 CLEAR trial showed significant survival benefits with the combination when compared with lenvatinib-everolimus or sunitinib monotherapy.FDA Approvals (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - August 12, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Alert Source Type: news

FDA approves lenvatinib plus pembrolizumab for advanced renal cell carcinoma
(Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - August 11, 2021 Category: Drugs & Pharmacology Authors: FDA Source Type: news

FDA Approves Keytruda (pembrolizumab) Plus Lenvima (lenvatinib) Combination for First-Line Treatment of Adult Patients With Advanced Renal Cell Carcinoma (RCC)
August 11, 2021 Keytruda Plus Lenvima Is Now Approved for Two Types of Cancer, Including Advanced RCC Based on Phase 3 CLEAR/KEYNOTE-581 Trial, Keytruda Plus Lenvima Significantly Reduced Risk of Disease Progression or Death by 61% Versus... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - August 11, 2021 Category: Drugs & Pharmacology Source Type: news

Second- and Later-Line Treatment of Metastatic RCC Second- and Later-Line Treatment of Metastatic RCC
When first-line treatments for metastatic renal cell carcinoma fail, what are the next options?Current Opinion in Urology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 19, 2021 Category: Consumer Health News Tags: Urology Journal Article Source Type: news

Urine Test Differentiates Kidney Cancer From Benign Lesions Urine Test Differentiates Kidney Cancer From Benign Lesions
For patients with kidney lesions, urine tests under development can differentiate renal cell cancer from benign masses, say investigators.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - July 16, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

New use of old drug reduces risk of kidney cancer returning
(European Association of Urology) Using an existing drug for late-stage kidney cancer at an earlier stage of the disease could reduce the risk of cancer recurring by a third, according to new research. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - July 10, 2021 Category: Cancer & Oncology Source Type: news

What Is the Main Cause of Kidney Cancer?
Title: What Is the Main Cause of Kidney Cancer?Category: Diseases and ConditionsCreated: 6/29/2021 12:00:00 AMLast Editorial Review: 6/29/2021 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - June 29, 2021 Category: Cancer & Oncology Source Type: news

New microscopy method reveals single childhood cancer cells in unprecedented detail
(Princess M á xima Center for Pediatric Oncology) A new technique to look at tumors under the microscope has revealed the cellular make-up of Wilm's tumors, a childhood kidney cancer, in unprecedented detail. This new approach could help understand how tumors develop and grow, and fuel research into new treatments for children's cancers. Scientists at the Princess M á xima Center for pediatric oncology developed a new imaging technique to study millions of cells in 3D tissue, revealing hundreds of features from each individual cell. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 24, 2021 Category: International Medicine & Public Health Source Type: news

Cellular signatures of kidney tumours discovered
(Wellcome Trust Sanger Institute) The origins of seven types of kidney cancer, including several rare subtypes, have been identified by researchers at the Wellcome Sanger Institute, Great Ormond Street Hospital (GOSH), the Princess M á xima Center for Pediatric Oncology and Oncode Institute. The findings confirm that these cancers have their origin in specific forms of developmental cells present in the maturing fetus. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 23, 2021 Category: Cancer & Oncology Source Type: news

Kidney cancer: The lesser-known danger sign found in the way you sleep warning of risk
KIDNEY cancer: Every year, more than 41,000 men and 24,000 women get kidney and renal pelvis cancers, and about 9,000 men and 5,000 women die from these diseases. As with most serious diseases, the earlier the detection and treatment, the better the outcome. If your sleeping habits have changed, this could be an early warning sign of kidney cancer. (Source: Daily Express - Health)
Source: Daily Express - Health - June 11, 2021 Category: Consumer Health News Source Type: news

FDA approves nivolumab plus cabozantinib for advanced renal cell carcinoma
Hematology / Oncology News Burst (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - June 11, 2021 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Ultrasound can determine lung congestion in kidney patients
Ultrasound is a useful guide in determining lung congestion for hemodialysi...Read more on AuntMinnie.comRelated Reading: CT shows that acute kidney injury common among COVID-19 patients Shorter lung ultrasound exams can help kidney disease patients Ultrasound AI model can help evaluate chronic kidney disease Brain imaging with CT, MRI in kidney cancer patients finds metastases Exposure to contrast on CTPA doesn't cause long-term kidney injury (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - June 10, 2021 Category: Radiology Source Type: news

Analysis reveals how kidney cancer develops and responds to treatment
(Michigan Medicine - University of Michigan) By sequencing the RNA of individual cells within multiple benign and cancerous kidney tumors, researchers from the University of Michigan Rogel Cancer Center have identified the cells from which different subtypes originate, the pathways involved and how the tumor microenvironment impacts cancer development and response to treatment. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 7, 2021 Category: Cancer & Oncology Source Type: news

Breakthroughs including a drug cure for kidney cancer unveiled at world's biggest cancer conference
A further wave of exciting cancer breakthroughs were unveiled at the American Society for Clinical Oncology's annual meeting. Here, we outline a handful of the most remarkable discoveries. (Source: the Mail online | Health)
Source: the Mail online | Health - June 5, 2021 Category: Consumer Health News Source Type: news

ASCO: Pembrolizumab Ups DFS in High-Risk Resected Clear-Cell RCC
FRIDAY, June 4, 2021 -- For patients with fully resected intermediate-high-risk or high-risk clear-cell renal cell carcinoma (ccRCC), adjuvant therapy with pembrolizumab yields a significant and clinically meaningful improvement in disease-free... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 4, 2021 Category: Pharmaceuticals Source Type: news

Adjuvant Immunotherapy Benefit in Resected Kidney Cancer Adjuvant Immunotherapy Benefit in Resected Kidney Cancer
After surgery, progression-free survival was significantly longer for patients with high-risk renal carcinoma who received immunotherapy with pembrolizumab than for those who received placebo.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - June 3, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Immunotherapy drug delays recurrence in kidney cancer patients
(Dana-Farber Cancer Institute) Treatment with an immunotherapy drug following kidney cancer surgery, prolonged disease-free survival rates in patients at high risk for recurrence, according to an interim report of a phase 3 clinical trial of adjuvant immunotherapy in this patient population. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 3, 2021 Category: Cancer & Oncology Source Type: news

Ultrasound AI model can help evaluate chronic kidney disease
Artificial intelligence (AI)-based analysis of kidney ultrasound studies coul...Read more on AuntMinnie.comRelated Reading: Brain imaging with CT, MRI in kidney cancer patients finds metastases AI plus CT improves liver steatosis assessment CEUS helps predict chronic kidney disease progression Caution indicated with new GBCAs for kidney patients Prehydration not needed before contrast CT of kidneys (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - May 24, 2021 Category: Radiology Source Type: news

Dana-Farber researchers present key studies at ASCO annual meeting
(Dana-Farber Cancer Institute) Dana-Farber Cancer Institute researchers are presenting at the 2021 Annual Meeting of the American Society of Clinical Oncology (ASCO). Toni K. Choueiri, MD, will present results from the randomized, double-blind, phase III KEYNOTE-564 trial evaluating pembrolizumab versus placebo after surgery in patients with renal cell carcinoma during ASCO's Plenary Session. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 20, 2021 Category: Cancer & Oncology Source Type: news

New single-cell analysis tool links immune cells to kidney cancer recurrence
(Columbia University Irving Medical Center) Newly identified immune cells infiltrate tumors in patients with localized kidney cancer and may be driving the cancer's recurrence, Columbia researchers have found. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 20, 2021 Category: Cancer & Oncology Source Type: news

'3D amplified' MRI technique shows how the brain moves
A new MRI technique called 3D amplified MRI (3D aMRI) can visualize brain motio...Read more on AuntMinnie.comRelated Reading: Brain imaging with CT, MRI in kidney cancer patients finds metastases CT results in COVID-19 patients predict abnormal brain MRI findings MRI leads the way in neuroimaging innovation MGH researchers develop portable MRI scanner Working group uses MRI to analyze brain trauma (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - May 6, 2021 Category: Radiology Source Type: news

How Is Kidney Cancer Diagnosed?
Title: How Is Kidney Cancer Diagnosed?Category: Diseases and ConditionsCreated: 5/6/2021 12:00:00 AMLast Editorial Review: 5/6/2021 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - May 6, 2021 Category: Cancer & Oncology Source Type: news

Kidney cancer risks higher for Hispanic, Native Americans in Arizona
(University of Arizona Health Sciences) Dr. Ken Batai,has documented an increased risk of mortality among Arizona's Hispanic American and Native American kidney cancer patients. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 6, 2021 Category: Cancer & Oncology Source Type: news

Occult Brain Mets Detected in Patients With Advanced Renal Cancer
Asymptomatic brain metastases incidentally diagnosed in about 4 percent of patients with mRCC during clinical trial screening (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - May 3, 2021 Category: Cancer & Oncology Tags: Nephrology, Neurology, Oncology, Radiology, Journal, Source Type: news

Occult Brain Mets Detected in Patients With Advanced Renal Cancer
MONDAY, May 3, 2021 -- Occult brain metastasis is identified in about 4 percent of patients with metastatic renal cell carcinoma (mRCC), according to a study published in the April issue of the Journal of the National Comprehensive Cancer... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 3, 2021 Category: Pharmaceuticals Source Type: news

Metastatic renal-cell carcinoma treated with first-line monotherapy: considerable burden, high unmet needs
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - April 30, 2021 Category: Drugs & Pharmacology Source Type: news

Biocon Biologics, Viatris receive approval for cancer drug
Abevmy is approved for treatment in metastatic colorectal carcinoma, metastatic breast cancer, non small-cell lung carcinoma, glioblastoma, ovarian, cervical and renal cancer as part of a specific regimen. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 26, 2021 Category: Pharmaceuticals Source Type: news

MRI valuable in identifying breast lesions, study finds
MRI demonstrates superb performance in identifying breast lesions where surgica...Read more on AuntMinnie.comRelated Reading: Brain imaging with CT, MRI in kidney cancer patients finds metastases Women of color still face barriers in breast cancer treatment COVID-19 has had dramatic effect on breast imaging Liquid biopsy enhances MRI studies of breast cancer patients Cuzick: It's time to think about risk-adapted breast cancer screening (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - April 21, 2021 Category: Radiology Source Type: news

MRI valuable in identifying breast lesions, study says
MRI demonstrates superb performance in identifying breast lesions where surgica...Read more on AuntMinnie.comRelated Reading: Brain imaging with CT, MRI in kidney cancer patients finds metastases Women of color still face barriers in breast cancer treatment COVID-19 has had dramatic effect on breast imaging Liquid biopsy enhances MRI studies of breast cancer patients Cuzick: It's time to think about risk-adapted breast cancer screening (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - April 20, 2021 Category: Radiology Source Type: news

What Are the Early Signs of Kidney Cancer?
Title: What Are the Early Signs of Kidney Cancer?Category: Diseases and ConditionsCreated: 4/19/2021 12:00:00 AMLast Editorial Review: 4/19/2021 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - April 19, 2021 Category: Cancer & Oncology Source Type: news

Brain imaging with CT, MRI in kidney cancer patients finds metastases
Baseline brain imaging using CT or MRI in patients with metastatic kidney cance...Read more on AuntMinnie.comRelated Reading: CT results in COVID-19 patients predict abnormal brain MRI findings CT-guided renal ablation is safe for treating cancer in obese patients MRI leads the way in neuroimaging innovation MGH researchers develop portable MRI scanner Working group uses MRI to analyze brain trauma (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - April 14, 2021 Category: Radiology Source Type: news

JNCCN Study: Important potential role for routine brain imaging in advanced kidney cancer
(National Comprehensive Cancer Network) The April 2021 issue of JNCCN--Journal of the National Comprehensive Cancer Network publishes new research from Memorial Sloan Kettering Cancer Center (MSK) and Gustave Roussy Institute, which suggests that baseline brain imaging should be considered in most patients with metastatic kidney cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 13, 2021 Category: Cancer & Oncology Source Type: news

FDA D.I.S.C.O. Burst Edition: FDA approval of Fotivda (tivozanib) for adult patients with relapsed or refractory advanced renal cell carcinoma following two or more prior systemic therapies
Listen to a soundcast of the March 10, 2021 FDA approval of Fotivda (tivozanib) for adult patients with relapsed or refractory advanced renal cell carcinoma following two or more prior systemic therapies. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - April 9, 2021 Category: Drugs & Pharmacology Authors: FDA Source Type: news

FDA clears IceCure Medical's cryoablation system
The U.S. Food and Drug Administration (FDA) has granted breakthrough devic...Read more on AuntMinnie.comRelated Reading: 3 topics shaping the future of women's imaging Cryoablation comparable to surgery for kidney cancer MRI-guided cryoablation a boon for HCC patients US-guided breast cryoablation offers new treatment option SIR: Cryoablation relieves phantom limb pain (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - April 6, 2021 Category: Radiology Source Type: news

Obesity Tied to Increased Mortality Overall in Patients With Cancer
Risk for death lower for patients with lung cancer, renal cell carcinoma, melanoma with versus without obesity (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - March 30, 2021 Category: Cancer & Oncology Tags: Dermatology, Gastroenterology, Gynecology, Internal Medicine, Nephrology, Oncology, Pathology, Pulmonology, Radiology, Journal, Source Type: news

Getting a Prescription to Die Remains Tricky Even As Aid-in-Dying Bills Gain Momentum Across the U.S.
Linda Heim knew her dad didn’t plan to wait for the cancer to kill him. For decades, he’d lived in Montana, which they’d thought was one of the few places where terminally ill people could get a prescription to end their life. After two years of being sick, Heim’s dad got the diagnosis in 2019: stage 4 kidney cancer. His physician offered treatments that might extend his life by months. Instead, the 81-year-old asked the doctor for help dying. Heim said her parents left the appointment in their hometown of Billings with two takeaways: The legality of medically assisted death was questionable in Mont...
Source: TIME: Health - March 29, 2021 Category: Consumer Health News Authors: Katheryn Houghton / Kaiser Health News Tags: Uncategorized COVID-19 Source Type: news

Aveo boosted headcount sixfold in leadup to drug launch
Leading up to Aveo Oncology's first-ever FDA approval last week of a kidney cancer drug called Fotivda, the company has multiplied its headcount sixfold over the past year. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - March 15, 2021 Category: Biotechnology Authors: Don Seiffert Source Type: news

Aveo boosted headcount sixfold in leadup to drug launch
Leading up to Aveo Oncology's first-ever FDA approval last week of a kidney cancer drug called Fotivda, the company has multiplied its headcount sixfold over the past year. (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - March 15, 2021 Category: American Health Authors: Don Seiffert Source Type: news

High BMI Tied to Better Overall Survival in Immune Checkpoint Inhibitor-Treated Metastatic RCC High BMI Tied to Better Overall Survival in Immune Checkpoint Inhibitor-Treated Metastatic RCC
In patients with metastatic renal cell carcinoma treated with PD-1/PD-L1-based immune checkpoint inhibitors (ICIs), higher body mass index was associated with improved overall survival in a database study.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 15, 2021 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Mayo Clinic Q & amp;A podcast: Kidney cancer often found by accident
Your kidneys remove waste from your blood and regulate a healthy balance between water, sodium and minerals in your bloodstream. "Kidneys filter intoxicants, drugs and waste products out of your blood," says Dr. Scott Cheney, a Mayo Clinic urologic surgeon. "We would actually die within about a week without having good kidney function." Poor kidney [...] (Source: Mayo Clinic Research News)
Source: Mayo Clinic Research News - March 15, 2021 Category: Research Source Type: news

FOTIVDA (tivozanib), FDA Approved for Treatment of Relapsed/Refractory Advanced Renal Cell Carcinoma, Available at Biologics by McKesson
CARY, N.C., March 12, 2021 —Biologics by McKesson, an independent specialty pharmacy specializing in oncology and rare disease areas, was selected by AVEO Oncology as a specialty pharmacy provider for FOTIVDA® (tivozanib) for the treatment of adult patients with relapsed or refractory advanced renal ... (Source: McKesson News)
Source: McKesson News - March 12, 2021 Category: Information Technology Source Type: news

Dana-Farber research leads to better understanding of the immune system in kidney cancer
(Dana-Farber Cancer Institute) In two new studies published today in Cancer Cell, researchers from Dana-Farber Cancer Institute and the Broad Institute of MIT and Harvard used the emerging technology of single-cell RNA sequencing to draw a clearer picture of how kidney tumors' microenvironments change in response to immunotherapy. The researchers believe that this work points to potential targets for new drug therapies. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - March 11, 2021 Category: Cancer & Oncology Source Type: news

Aveo finally earns approval for kidney cancer drug
More than 14 years after Boston-based Aveo Oncology licensed an experimental cancer drug from a Japanese biotech, the company announced Wednesday that the drug has earned approval by the U.S. Food and Drug Administration to treat kidney cancer, ending a long and tumultuous journey. The pill has the generic name of tivozanib, and will be marketed under the brand name, Fotivda, for use by patients with relapsed or refractory advanced renal cell carcinoma who have tried at least two other drugs previously. The… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - March 10, 2021 Category: Pharmaceuticals Authors: Don Seiffert Source Type: news